Coronavirus: Screening

(asked on 1st June 2020) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what criteria his Department uses to assess companies for participation in the national covid-19 antibody testing programme.


Answered by
Nadine Dorries Portrait
Nadine Dorries
This question was answered on 18th June 2020

Securing the most appropriate antibody assays for our testing programme is vitally important. We have been clear that any antibody test being deployed needs to meet the target product profile published by the Medicines and Healthcare products Regulatory Agency (MHRA).

Target Product Profiles describe the minimum and desirable levels of clinical performance and related characteristics and are regularly refreshed to reflect the emerging science and clinical evidence regarding serology testing. In addition, we will take into account the ability of the company to meet our needs for rapid deployment and scalability across the United Kingdom, along with their willingness to work with the Government to ensure we deliver value for money to the UK taxpayer.

Reticulating Splines